The Good News For Novavax Ahead Of Its Quarterly Report
is expected late Tuesday to report diminishing losses and double-digit sales growth for the fourth quarter. Ahead of the report, NVAX stock surged. The company makes a Covid vaccine called Nuvaxovid. In the U.S., it's allowed for people age 12 and older as a primary series of shots. The Food and…
#nvax #nuvaxovid #novavax #seagensoars